Day: September 21, 2022

FRISCO, TX, Sept. 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Verde Bio Holdings, Inc. (OTCQB: VBHI) (www.verdebh.com), a growing oil and gas company, today announced that it has entered into an agreement with a private buyer for the sale of two of its assets for a combined sales price of $1,068,300. The transaction is scheduled to close on or before October 21, 2022, with an effective date of December 1, 2022, pending buyer due diligence. Verde Bio Holdings will achieve approximately a 78% profit with the sales price alone, which combined with revenue generated from holding the assets for a little over a year equates to a significant return to the company on its investment in the assets. In addition to the profits and previous revenue mentioned above, Verde also will receive all revenue of the assets related to production from...

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) —  OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Strawberry Fields REIT, Inc. (OTCQX: STRW), a Real Estate Investment Trust specializing in buying and leasing senior healthcare facilities, has gone public on the OTCQX® Best Market. Strawberry Fields REIT, Inc. begins trading today on OTCQX under the symbol “STRW.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market offers private companies an efficient pathway to go public.  To qualify for OTCQX, companies must meet high financial standards, be current in their disclosure, follow best practice corporate governance, and demonstrate compliance with applicable securities...

Eric J. Ende, MD, MBA Appointed as Chairman, Effective October 1, 2022; Founding Chairman Herbert J. Conrad to Remain an Independent Director of the Company BEDMINSTER, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform delivery technology, today announced its leadership succession plan, with the Board of Directors unanimously appointing current board member, Eric J. Ende, to succeed Herbert J. Conrad as Chairman of the Board. Mr. Conrad, the founding Chairman of Matinas will remain on the Board as an independent director of the Company. The succession will be effective October 1, 2022. “This change is representative of...

VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has recently received a cash payment of approximately CDN $450K from a refundable tax credit program from its clinical research work in Australia. “Algernon tries to conduct as much of its clinical research in Australia as possible because of the 43.5% refundable R&D tax credit program,” said Christopher J. Moreau, CEO of Algernon. “This brings our total cash refund received to date to over CDN $3.0M, which has been an important part of Algernon’s capital efficient business model.” Additionally, the Company announces changes to the warrants that it issued on July 4, 2022,...

GREENWICH, Conn. , Sept. 21, 2022 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading provider of freight transportation services, has been named to the 2023 FreightTech 100 by FreightWaves, a global source for supply chain market intelligence. RXO, the planned spin-off of XPO’s tech-enabled brokered transportation platform, was also named to the list. The FreightTech 100 list recognizes the most innovative companies in the transportation industry.  Mario Harik, XPO’s chief information officer and incoming chief executive officer, said, “We’ve spent more than $3 billion on technology over the last 11 years to ensure we’re helping our customers move goods through their supply chains as efficiently as possible. We’re honored to be recognized by FreightWaves for our technological innovation as we move XPO closer to becoming...

Multinational operator partners with House of Kush to grow and commercialize THC smokable flower from House of Kush’s genetics outside of the United States and Canada TOCANCIPÁ, Colombia, Sept. 21, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced a partnership today with U.S. cannabis-branded genetic innovation company, House of Kush, to be the exclusive grower and distributor of proprietary genetics globally. Clever Leaves will be the exclusive producer of various genetics for House of Kush outside of the United States and Canada. As the exclusive grower for House of Kush globally, Clever Leaves will cultivate and commercialize House of Kush proprietary genetics in its Colombia and Portugal facilities...

69% of companies admit they knew about breaches or exposures due to variations in multi-cloud security configurations 70% of companies are not confident in their ability to apply consistent security across on-premise and multi-cloud environments Less than half of organizations trust their security staff to maintain a strong security postureMAHWAH, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, today released its new report, Application Security in a Multi-Cloud World. The survey, which was conducted with Osterman Research, reveals that organizations continue to struggle to achieve consistent, high quality application security across hybrid and multi-cloud environments. “While many organizations are running multiple tools to secure applications...

KNOXVILLE, TN, Sept. 21, 2022 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that the Company has entered into an option agreement with the University of Miami (UM) for an exclusive worldwide license of intellectual property developed by the Ophthalmic Biophysics Center (OBC) of Bascom Palmer Eye Institute (BPEI), which is part of the UM Health System, for the use of OBC’s photodynamic antimicrobial therapy (PDAT) medical device in combination with Provectus’ proprietary pharmaceutical-grade rose bengal for the treatment of bacterial, fungal, and viral infections of the eye. The Company also initiated a sponsored research program with OBC to investigate Provectus’ rose bengal for the treatment of infectious keratitis. Established in 1970 by BPEI founding director Edward W.D. Norton, MD and Jean-Marie Parel, IngETS-G,...